Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Pegasus Biologics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Pegasus Biologics

Pegasus Biologics

Pre-Seed

Pegasus Biologics manufactures and markets bioimplants for soft tissue repair and wound care, serving various medical fields.

HQ
Irvine, CA, US
Founded
2003
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to advance medical treatments, Pegasus Biologics specializes in manufacturing and marketing bioimplants for soft tissue repair and wound care. Their core products include the OrthADAPT Bioimplant, designed for the repair and reinforcement of tendons and ligaments, and the Unite Biomatrix, an enzyme-resistant collagen scaffold for suture retention and intrinsic strength. The company primarily serves the orthopedics, sports medicine, and neurosurgery markets, focusing on improving patient outcomes in these specialized fields.

Pegasus Biologics has garnered attention for its innovative approach to bioimplant technology. Notable affiliated individuals include leading researchers and medical professionals who contribute to the company's R&D efforts. The company has achieved significant milestones in product development, including FDA approvals and successful clinical trials. Its impact is evident in the enhanced recovery and quality of life for patients undergoing soft tissue repair procedures.

Pegasus Biologics - Similar Companies

Bone Biologics logo

Bone Biologics

Biomimedica logo

Biomimedica

biomimedica.com

BioPoly logo

BioPoly

biopolyortho.com

Circle Biologics logo

Circle Biologics

NeXtGen Biologics logo

NeXtGen Biologics

Colorado Therapeutics logo

Colorado Therapeutics

Miach Orthopaedics logo

Miach Orthopaedics

miachortho.com

Tela Bio logo

Tela Bio

telabio.com

Glycologix logo

Glycologix

glycologix.com

Novum Medical logo

Novum Medical

RevBio logo

RevBio

Imbed Biosciences logo

Imbed Biosciences

imbedbio.com

MiMedx Group logo

MiMedx Group

mimedx.com

Asante Bio logo

Asante Bio

asantebio.com

OsteoNovus logo

OsteoNovus

osteonovus.com

Pegasus Biologics - Quick Facts

Who are Pegasus Biologics' competitors?

Companies similar to Pegasus Biologics include Bone Biologics, Biomimedica, BioPoly and Circle Biologics.

When was Pegasus Biologics founded?

Pegasus Biologics was founded in 2003.

Where is Pegasus Biologics' headquarters located?

Pegasus Biologics' headquarters is located in Irvine, CA, US.

When was Pegasus Biologics' last funding round?

Pegasus Biologics' most recent funding round was for $1M (USD) in June 2009.

How much has Pegasus Biologics raised to-date?

As of Jun 6, 2009, Pegasus Biologics has raised a total of $32.7M (USD).

How many employees does Pegasus Biologics have?

Pegasus Biologics has 75 employees as of Feb 5, 2024.

Pegasus Biologics - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Bioimplants
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research